Chemspace, Enamine, and PharmAI GmbH Discovery (PAID) start a transformative collaboration to accelerate the advancement of theranostics through AI-driven drug discovery with an emphasis on cancer diagnosis and therapy.

This collaboration brings together the success of Enamine’s discovery biology and chemistry competencies, Chemspace’s expertise in ultra-large chemical space exploration for drug discovery, and PAID’s AI-powered molecular discovery platform to identify and develop promising drug candidates faster and with greater precision, both for conventional and molecular radiotherapy and radio diagnostics.

More details here: https://lnkd.in/eXdAMmrT